We report sustained remission of chronic active Epstein-Barr virus (EBV) infection in a 27-
year-old female patient treated with third-party EBV-specific T cells followed by allogeneic …

Immunosuppressed patients are susceptible to virus reactivation or de novo infection.
Adoptive immunotherapy, based on virus-specific T lymphocytes (VST), can prevent or treat …

Reactivation of Human Cytomegalovirus (HCMV) and Human Adenovirus (HAdV) in
immunocompromised patients following stem cell transplantation (SCT) or solid organ …

Introduction: Viral infections and reactivations still remain a cause of morbidity and mortality
after hematopoietic stem cell transplantation due to immunodeficiency and …

Infection remains a major challenge after hematopoietic stem cell transplantation [1]. In
transplant recipients, reactivation of herpes viruses, especially of the human …

The development of new therapies for COVID-19 high-risk patients remains necessary to
prevent additional deaths. Here, we studied the phenotypical and functional characteristics …

Complications due to HCMV infection or reactivation remain a challenging clinical problem
in immunocompromised patients, mainly due to insufficient or absent T‐cell functionality …

Abstract Purpose of Review Infectious diseases contribute significantly to morbidity and
mortality in recipients of allogeneic haematopoietic stem cell transplantation (aHSCT) …

Background Adoptive transfer of virus-specific T cells (VSTs) represents a prophylactic and
curative approach for opportunistic viral infections and reactivations after transplantation …

Wilms tumor protein-1 (WT1) is an attractive target for adoptive T-cell therapy due to its
expression in solid tumors and hematologic malignancies. However, T cells recognizing …